24 Haymarket Bbi (Kcp Nominees) Limited investment portfolio

Azadyne Ltd is a pre‑clinical biotechnology company developing novel therapeutics that target autoimmune diseases—including multiple sclerosis, rheumatoid arthritis and inflammatory bowel disease—by leveraging a queuine‑based mechanism, with drug candidates advancing toward first‑in‑human trials.

Previsico provides a real‑time, street‑level flood forecasting and warning platform (Flood Intel) that generates hyper‑local surface‑water flood alerts. Its service is sold to organisations that manage flood‑exposed assets, such as utilities, insurers, local authorities, property owners and businesses in sectors including construction, transport, housing and other asset‑intensive industries.